Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Papayianni, A.
Right arrow Articles by Memmos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papayianni, A.
Right arrow Articles by Memmos, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 435-441
© 2002 European Renal Association-European Dialysis and Transplant Association

Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events

Aikaterini Papayianni, Efstathios Alexopoulos, Panagiotis Giamalis, Lazaros Gionanlis, Anna-Maria Belechri, Paraschos Koukoudis and Dimitrios Memmos

Department of Nephrology, Hippokration General Hospital, Thessaloniki, Greece

Background. Increased levels of circulating adhesion molecules and chemokines have been reported in haemodialysis (HD) patients but the influence of the HD membranes on their secretion, as well as their pathophysiological implications, remains largely unknown.

Methods. Circulating levels of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and monocyte chemoattractant protein-1 (MCP-1) were measured by immunosorbent assay (ELISA) in 81 HD patients (45 male, mean age 57±13 years) and 35 normal subjects. All patients had been stabilized on renal replacement therapy for >3 months and were free of active infection. Thirty-three patients (40.7%) were routinely dialysed with modified cellulose membranes and 48 patients (59.3%) were dialysed with polysulfone membranes. Blood samples were taken directly from the arteriovenous fistula immediately before and at the end of a routine HD session.

Results. Pre-dialysis levels were significantly elevated in HD patients compared with controls (ICAM-1 515±177 vs 238±64 ng/ml, P<0.0001; VCAM-1 2107±648 vs 1012±115 ng/ml, P<0.0001; MCP-1 427±148 vs 125±42 pg/ml, P<0.0001). The HD session resulted in a significant increase in the levels of all three molecules measured (515±177 vs 679±187 ng/ml, P<0.0001; 2107±648 vs 2662±800 ng/ml, P<0.0001; 427±148 vs 567±153 pg/ml, P<0.0001, respectively). There was no difference in pre- or post-dialysis levels of the above molecules between patients routinely dialysed with either modified cellulose or polysulfone membranes. MCP-1 levels had a positive correlation with ICAM-1 levels (r=0.41, P<0.0005). VCAM-1 levels had a negative correlation with HDL levels (r=-0.30, P<0.01) and were significantly elevated in patients with HDL <35 mg/dl compared with patients with HDL >=35 mg/dl (2300±606 vs 1890±633 ng/ml, P<0.005). Log-transformed exact C-reactive protein (CRP) values were significantly correlated with ICAM-1 and VCAM-1 levels (r=0.41, P<0.005 and r=0.43, P<0.005, respectively). In addition, compared with patients with normal CRP values, patients with elevated CRP had significantly increased levels of ICAM-1 (466±166 vs 580±172 ng/ml, P<0.005). Patients with cardiovascular, cerebrovascular, or peripheral vascular diseases had significantly increased serum CRP and ICAM-1 levels compared with patients with no evidence of vascular disease (19.2±12.9 vs 7.9±11.8 mg/l, P<0.001 and 608±189 vs 474±155 ng/ml, P<0.005 respectively).

Conclusions. Serum levels of ICAM-1, VCAM-1, and MCP-1 are increased in HD patients and probably result from either inadequate clearance or enhanced synthesis and release. HD session resulted in a significant increase of the above molecule levels but the exact mechanism(s) responsible for these alterations are yet to be fully elucidated. Increased levels of adhesion molecules are associated with inflammation, dyslipidaemia, and cardiovascular events. However, the potential link between these processes and its clinical significance warrants further investigation.

Keywords: adhesion molecules; atherosclerosis; cardiovascular disease; chemokines; haemodialysis

Correspondence and offprint requests to: Aikaterini Papayianni, MD, Department of Nephrology, Hippokration General Hospital, 50 Papanastasiou Str., 54642 Thessaloniki, Greece. Email: aikpapag{at}otenet.gr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
L. Piemonti, G. Calori, G. Lattuada, A. Mercalli, F. Ragogna, M. P. Garancini, G. Ruotolo, L. Luzi, and G. Perseghin
Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
Diabetes Care, November 1, 2009; 32(11): 2105 - 2110.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
P. C. Fortes, P. H. Versari, A. E.M. Stinghen, and R. Pecoits-Filho
CONTROLLING INFLAMMATION IN PERITONEAL DIALYSIS: THE ROLE OF PD-RELATED FACTORS AS POTENTIAL INTERVENTION TARGETS
Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S76 - S81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. Castilla, R. Echarri, A. Davalos, F. Cerrato, H. Ortega, J. L. Teruel, M. F. Lucas, D. Gomez-Coronado, J. Ortuno, and M. A Lasuncion
Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 252 - 262.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Arici, S. Kahraman, G. Genctoy, B. Altun, U. Kalyoncu, A. Oto, S. Kirazli, Y. Erdem, U. Yasavul, and C. Turgan
Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 999 - 1005.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. P. C. Grooteman, M. Gritters, I. M. P. M. J. Wauters, C. G. Schalkwijk, F. Stam, J. Twisk, P. M. ter Wee, and M. J. Nube
Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2751 - 2758.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. C. Wolf, G. Sauter, H.-P. Rodemann, T. Risler, and B. R. Brehm
Influence of growth factors on the proliferation of vascular smooth muscle cells isolated from subtotally nephrectomized rats after endothelin or angiotensin II antagonism
Nephrol. Dial. Transplant., February 1, 2005; 20(2): 312 - 318.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. P. C. Grooteman and M. J. Nube
Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter?
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2965 - 2970.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Bro, F. Moeller, C. B. Andersen, K. Olgaard, and L. B. Nielsen
Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E-Deficient Mice
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1495 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Amann, M.-L. Gross, and E. Ritz
Pathophysiology Underlying Accelerated Atherogenesis in Renal Disease: Closing in on the Target
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1664 - 1666.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. van de Kerkhof, C. G. Schalkwijk, C. J. Konings, E. C. Cheriex, F. M. van der Sande, P. G. Scheffer, P. M. ter Wee, K. M. Leunissen, and J. P. Kooman
N {epsilon}-(carboxymethyl)lysine, N {epsilon}-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients
Nephrol. Dial. Transplant., April 1, 2004; 19(4): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. Piemonti, G. Calori, A. Mercalli, G. Lattuada, P. Monti, M. P. Garancini, F. Costantino, G. Ruotolo, L. Luzi, and G. Perseghin
Fasting Plasma Leptin, Tumor Necrosis Factor-{alpha} Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant Women: Impact on cardiovascular mortality
Diabetes Care, October 1, 2003; 26(10): 2883 - 2889.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Bro, J. F. Bentzon, E. Falk, C. B. Andersen, K. Olgaard, and L. B. Nielsen
Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E-Deficient Mice
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2466 - 2474.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. A. de Lemos, D. A. Morrow, M. S. Sabatine, S. A. Murphy, C. M. Gibson, E. M. Antman, C. H. McCabe, C. P. Cannon, and E. Braunwald
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes
Circulation, February 11, 2003; 107(5): 690 - 695.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Papagianni, M. Kalovoulos, D. Kirmizis, A. Vainas, A.-M. Belechri, E. Alexopoulos, and D. Memmos
Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients
Nephrol. Dial. Transplant., January 1, 2003; 18(1): 113 - 119.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.